March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Reanalysis of Urothelial Cancer Chemoimmunotherapy Trials With Differential Censoring
Jan 29, 2025, 07:56

Reanalysis of Urothelial Cancer Chemoimmunotherapy Trials With Differential Censoring

Laura Bukavina, Urologic Oncologist at Cleveland Clinic Urology, shared a post on X:

“When control patients drop out for better options, outcomes get skewed equals perceived inferiority bias

In Bladder Cancer trials this bias inflated PFS/OS for chemo + IO. Adjustments erased OS (nivolumab, CheckMate901) and PFS (pembrolizumab, KEYNOTE-361). RCT are not perfect.”

Reanalysis of Urothelial Cancer Chemoimmunotherapy Trials With Differential Censoring

Authors: Tomer Meirson, Jonathan Ofer,  Noa Zimhony-Nissim, Avital Bareket-Samish,  Gal Markel,  Victoria Neiman, Nathan Cherny, Daniel A. Goldstein,  Bishal Gyawali, Ian Tannock, Eli Rosenbaum.

Reanalysis of Urothelial Cancer Chemoimmunotherapy Trials With Differential Censoring